TASMAR

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug TASMAR contains one active pharmaceutical ingredient (API):

1 Tolcapone
UNII CIF6334OLY - TOLCAPONE

Tolcapone is an orally active, selective and reversible catechol-O-methyltransferase (COMT) inhibitor. Administered concomitantly with levodopa and an aromatic amino acid decarboxylase inhibitor (AADC-I), it leads to more stable plasma levels of levodopa by reducing metabolism of levodopa to 3-methoxy-4-hydroxy-L-phenylalanine (3-OMD). High levels of plasma 3-OMD have been associated with poor response to levodopa in Parkinson’s disease patients.

Read about Tolcapone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TASMAR Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N04BX01 Tolcapone N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BX Other dopaminergic agents
Discover more medicines within N04BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 512003001119311
Country: EE Ravimiamet Identifier(s): 1196928, 1196939, 1196940, 1196951, 1196962, 1196973, 1598496
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 97044003
Country: FR Base de données publique des médicaments Identifier(s): 67077388
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 90611
Country: IE Health Products Regulatory Authority Identifier(s): 49675
Country: IT Agenzia del Farmaco Identifier(s): 033280025, 033280037, 033280049, 033280064, 033280076, 033280088, 033280090, 033280102, 033280114
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1031010, 1031011, 1031012, 1031013, 1031014, 1031015, 1031016, 1031017, 1081084
Country: NL Z-Index G-Standaard, PRK Identifier(s): 80179
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 7360
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100083537, 100085097
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8698856090010
Country: US FDA, National Drug Code Identifier(s): 0187-0938
Country: ZA Health Products Regulatory Authority Identifier(s): 31/5.4.1/0396

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.